Reilly M. Eason
Research Subjects
Research Interests
Reilly M. Eason has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Charles See Yeung
Merck & Co., Inc. Boston Massachusetts USA
1 shared publication - G. Logan Bartholomew
Department of Chemistry University of California, Berkeley Berkeley California 94720 USA
1 shared publication - Lucas J. Karas
University of Utah
1 shared publication - Matthew S. Sigman
University of Utah
1 shared publication - Richmond Sarpong
Department of Chemistry, University of California, Berkeley, CA 94720, USA
1 shared publication
Latest Publications
- Open Access
- 18 November 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Cheminformatic Analysis of Core-Atom Transformations in Pharmaceutically Relevant Heteroaromatics
Heteroaromatics are the basis for many pharmaceuticals. The ability to modify these structures through selective core-atom transformations, or "skeletal edits", can dramatically expand the landscape for drug discovery and development. However, despite the importance of core-atom modifications, the quantitative impact of such transformations on accessible chemical space remains undefined. Here, we report a cheminformatic platform to analyze which skeletal edits would most increase access to novel chemical space. This study underscores the significance of emerging single and multiple core-atom transformations in heteroaromatics in enhancing chemical diversity, for example, at a late-stage of a drug discovery campaign. Our findings provide a quantitative framework for prioritizing core-atom modifications in heteroaromatic structural motifs, calling for the development of new methods to achieve these types of transformations.
- 18 November 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCheminformatic Analysis of Core-Atom Transformations in Pharmaceutically Relevant Heteroaromatics
Heteroaromatics are the basis for many pharmaceuticals. The ability to modify these structures through selective core-atom transformations, or "skeletal edits", can dramatically expand the landscape for drug discovery and development. However, despite the importance of core-atom modifications, the quantitative impact of such transformations on accessible chemical space remains undefined. Here, we report a cheminformatic platform to analyze which skeletal edits would most increase access to novel chemical space. This study underscores the significance of emerging single and multiple core-atom transformations in heteroaromatics in enhancing chemical diversity, for example, at a late-stage of a drug discovery campaign. Our findings provide a quantitative framework for prioritizing core-atom modifications in heteroaromatic structural motifs, calling for the development of new methods to achieve these types of transformations.